William K. Mcvicar - Net Worth and Insider Trading
William K. Mcvicar Net Worth
The estimated net worth of William K. Mcvicar is at least $198 dollars as of 2024-11-13. William K. Mcvicar is the Director of Salarius Pharmaceuticals Inc and owns about 133 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $198. Details can be seen in William K. Mcvicar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William K. Mcvicar has not made any transactions after 2022-06-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William K. Mcvicar
William K. Mcvicar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William K. Mcvicar owns 2 companies in total, including Salarius Pharmaceuticals Inc (SLRX) , and Rocket Pharmaceuticals Inc (RCKT) .
Click here to see the complete history of William K. Mcvicar’s form 4 insider trades.
Insider Ownership Summary of William K. Mcvicar
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2022-06-06 | director |
| RCKT | Rocket Pharmaceuticals Inc | 2016-03-22 | See Remarks |
William K. Mcvicar Latest Holdings Summary
William K. Mcvicar currently owns a total of 1 stock. William K. Mcvicar owns 133 shares of Salarius Pharmaceuticals Inc (SLRX) as of June 6, 2022, with a value of $198.
Latest Holdings of William K. Mcvicar
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2022-06-06 | 133 | 1.49 | 198 |
Holding Weightings of William K. Mcvicar
William K. Mcvicar Form 4 Trading Tracker
According to the SEC Form 4 filings, William K. Mcvicar has made a total of 2 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Salarius Pharmaceuticals Inc is the acquisition of 133 shares on June 6, 2022, which cost William K. Mcvicar around $5,045.
Insider Trading History of William K. Mcvicar
- 1
William K. Mcvicar Trading Performance
GuruFocus tracks the stock performance after each of William K. Mcvicar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William K. Mcvicar is 8.34%. GuruFocus also compares William K. Mcvicar's trading performance to market benchmark return within the same time period. The performance of stocks bought by William K. Mcvicar within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William K. Mcvicar's insider trading performs compared to the benchmark.
Performance of William K. Mcvicar
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.97 | | | | | |
| Relative Return to S&P 500(%) | 20.51 | | | | | |
William K. Mcvicar Ownership Network
Ownership Network List of William K. Mcvicar
Ownership Network Relation of William K. Mcvicar
William K. Mcvicar Owned Company Details
What does Salarius Pharmaceuticals Inc do?
Who are the key executives at Salarius Pharmaceuticals Inc?
William K. Mcvicar is the director of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include Exec VP Finance & Interim CFO Mark J Rosenblum , director & Chief Executive Officer David J. Arthur , and Chief Financial Officer Scott Jordan .
Salarius Pharmaceuticals Inc (SLRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc (SLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc (SLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Salarius Pharmaceuticals Inc (SLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Salarius Pharmaceuticals Inc Insider Transactions
William K. Mcvicar Mailing Address
Above is the net worth, insider trading, and ownership report for William K. Mcvicar. You might contact William K. Mcvicar via mailing address: C/o Inotek Pharmaceuticals Corporation, 131 Hartwell Avenue, Suite 105, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
